27811842|t|Inhibition of MHC-I by Brucella abortus is an early event during infection and involves EGFR pathway
27811842|a|Brucella abortus is able to persist inside the host despite the development of potent CD8(+) T-cell responses. We have recently reported the ability of B. abortus to inhibit the interferon-γ - induced major histocompatibility complex (MHC)-I cell surface expression on human monocytes. This phenomenon was due to the B. abortus -mediated retention of MHC-I molecules within the Golgi apparatus and was dependent on bacterial viability. However, the implications of bacterial virulence or replicative capacity and the signaling pathways remained unknown. Here we demonstrated that the B. abortus mutant strains RB51 and virB10(-) are able to inhibit MHC-I expression in the same manner as wild-type B. abortus, even though they are unable to persist inside human monocytes for a long period of time. Consistent with this, the phenomenon was triggered early in time and could be observed at 8 h postinfection. At 24 and 48 h, it was even stronger. Regarding the signaling pathway, targeting epidermal growth factor (EGF) receptor (EGFR), ErbB2 (HER2) or inhibition of tumor necrosis factor - α-converting enzyme, one of the enzymes which generates soluble EGF-like ligands, resulted in partial recovery of MHC-I surface expression. Moreover, recombinant EGF and transforming growth factor-α as well as the combination of both were also able to reproduce the B. abortus - induced MHC-I downmodulation. Finally, when infection was performed in the presence of an extracellular signal-regulated kinase 1/2 (Erk1/2) inhibitor, MHC-I surface expression was significantly recovered. Overall, these results describe how B. abortus evades CD8(+) T-cell responses early during infection and exploits the EGFR - ERK signaling pathway to escape from the immune system and favor chronicity.
27811842	14	19	MHC-I	T103	UMLS:C0019629
27811842	23	39	Brucella abortus	T007	UMLS:C0006304
27811842	65	74	infection	T038	UMLS:C3714514
27811842	88	100	EGFR pathway	T038	UMLS:C1155379
27811842	101	117	Brucella abortus	T007	UMLS:C0006304
27811842	187	200	CD8(+) T-cell	T017	UMLS:C0242629
27811842	201	210	responses	T038	UMLS:C0007613
27811842	253	263	B. abortus	T007	UMLS:C0006304
27811842	279	291	interferon-γ	T103	UMLS:C0021745
27811842	302	342	major histocompatibility complex (MHC)-I	T103	UMLS:C0019629
27811842	343	355	cell surface	T017	UMLS:C0699040
27811842	356	366	expression	T038	UMLS:C1171362
27811842	370	375	human	T204	UMLS:C0086418
27811842	376	385	monocytes	T017	UMLS:C0026473
27811842	418	428	B. abortus	T007	UMLS:C0006304
27811842	439	448	retention	T038	UMLS:C1753315
27811842	452	457	MHC-I	T103	UMLS:C0019629
27811842	479	494	Golgi apparatus	T017	UMLS:C0018042
27811842	618	636	signaling pathways	T038	UMLS:C0037080
27811842	685	695	B. abortus	T007	UMLS:C0006304
27811842	711	715	RB51	T007	UMLS:C2316069
27811842	720	729	virB10(-)	T033	UMLS:C1513916
27811842	750	755	MHC-I	T103	UMLS:C0019629
27811842	756	766	expression	T038	UMLS:C1171362
27811842	789	798	wild-type	T017	UMLS:C1883559
27811842	799	809	B. abortus	T007	UMLS:C0006304
27811842	832	838	unable	T033	UMLS:C1299582
27811842	857	862	human	T204	UMLS:C0086418
27811842	863	872	monocytes	T017	UMLS:C0026473
27811842	994	1007	postinfection	T038	UMLS:C0021387
27811842	1061	1078	signaling pathway	T038	UMLS:C0037080
27811842	1080	1089	targeting	T038	UMLS:C1159372
27811842	1090	1113	epidermal growth factor	T103	UMLS:C0242275
27811842	1115	1118	EGF	T103	UMLS:C0242275
27811842	1120	1128	receptor	T103	UMLS:C0034802
27811842	1130	1134	EGFR	T103	UMLS:C0034802
27811842	1137	1142	ErbB2	T103	UMLS:C0069515
27811842	1144	1148	HER2	T103	UMLS:C0069515
27811842	1167	1188	tumor necrosis factor	T103	UMLS:C0041368
27811842	1191	1210	α-converting enzyme	T103	UMLS:C1569773
27811842	1223	1230	enzymes	T103	UMLS:C0014442
27811842	1255	1271	EGF-like ligands	T103	UMLS:C3849998
27811842	1305	1310	MHC-I	T103	UMLS:C0019629
27811842	1311	1318	surface	T017	UMLS:C0699040
27811842	1319	1329	expression	T038	UMLS:C1171362
27811842	1341	1356	recombinant EGF	T103	UMLS:C0034861
27811842	1361	1389	transforming growth factor-α	T103	UMLS:C0040688
27811842	1443	1452	reproduce	T038	UMLS:C0035150
27811842	1457	1467	B. abortus	T007	UMLS:C0006304
27811842	1478	1483	MHC-I	T103	UMLS:C0019629
27811842	1514	1523	infection	T038	UMLS:C3714514
27811842	1560	1601	extracellular signal-regulated kinase 1/2	T103	UMLS:C0600388
27811842	1603	1609	Erk1/2	T103	UMLS:C0600388
27811842	1611	1620	inhibitor	T103	UMLS:C0014432
27811842	1622	1627	MHC-I	T103	UMLS:C0019629
27811842	1628	1635	surface	T017	UMLS:C0699040
27811842	1636	1646	expression	T038	UMLS:C1171362
27811842	1712	1722	B. abortus	T007	UMLS:C0006304
27811842	1730	1743	CD8(+) T-cell	T017	UMLS:C0242629
27811842	1744	1753	responses	T038	UMLS:C0007613
27811842	1767	1776	infection	T038	UMLS:C3714514
27811842	1794	1798	EGFR	T103	UMLS:C0034802
27811842	1801	1804	ERK	T103	UMLS:C0600388
27811842	1805	1822	signaling pathway	T038	UMLS:C0037080
27811842	1842	1855	immune system	T022	UMLS:C0020962